Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
In a six-generation consanguineous Han Chinese family, exome and Sanger sequencing identified compound heterozygous POMT1 variants c.1338+1G>A (p.His415LysfsTer3) and c.1457G>C (p.Trp486Ser) co-segregating with a later-onset limb-girdle muscular dystrophy phenotype (LGMD2K) characterised by progressive proximal pelvic and shoulder girdle weakness, joint contractures, intellectual disability, and elevated creatine kinase without structural brain or ocular defects (PMID:28157257). Segregation of both variants in two affected siblings supports autosomal recessive inheritance of LGMD2K.
Functional studies of POMT1 in Walker–Warburg syndrome demonstrate that patient-derived POMT1 truncating mutations abolish protein O-mannosyltransferase activity when co-expressed with POMT2 in Sf9 cells, indicating that loss of POMT1 enzymatic function underlies α-dystroglycan hypoglycosylation and muscle pathology (PMID:15522202).
Gene–Disease AssociationLimitedCompound heterozygous POMT1 variants in a single family with AR LGMD2K; no additional unrelated cases Genetic EvidenceLimited2 affected siblings with co-segregating variants in one pedigree [PMID:28157257] Functional EvidenceModeratePOMT1 truncating mutations abolish enzymatic activity in heterologous expression assays [PMID:15522202] |